Major Study Shows Liver Health Measured with cT1 Predicts Clinical Outcomes
May 7, 2025
New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease
March 18, 2025
Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development
November 14, 2024
CoverScan, Perspectum’s multi-organ MRI technology, has been nominated for the 2024 Prix Galien USA award for Best Digital Health Solution.
October 30, 2024
New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease
September 26, 2024
Dr Rajarshi Banerjee joins Amrita Sarkar, Principal Healthcare and Life Sciences Startups Business Development manager in this episode of the AWS Health Innovation Podcast.
August 27, 2024
New Study Uncovers Unprecedented Links Between Liver and Heart Health and the Importance of Doctors' Prioritizing Liver Health to Promote Heart Health
June 26, 2023
Perspectum and BluMaiden Biosciences Pte. Ltd. (“BluMaiden BioSciences”) Form Strategic Collaboration to Introduce Novel Insights into Clinical Trials
April 13, 2023
Perspectum Completes $19 Million Second Close of Series C Funding Led by Oppenheimer & Co. Inc. (“Oppenheimer”)
March 15, 2023
